Shares of 1Life Healthcare, Inc. (NASDAQ:ONEM – Get Rating) have received a consensus rating of “Hold” from the eighteen research firms that are covering the stock, Marketbeat.com reports. Ten equities research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $20.46.
A number of research analysts have issued reports on the company. Piper Sandler boosted their price target on 1Life Healthcare to $18.00 in a report on Friday, July 22nd. Stifel Nicolaus lowered shares of 1Life Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, July 27th. Evercore ISI lifted their price objective on shares of 1Life Healthcare to $18.00 in a report on Tuesday, August 9th. Deutsche Bank Aktiengesellschaft increased their target price on shares of 1Life Healthcare from $12.00 to $18.00 in a research note on Friday, July 22nd. Finally, Citigroup lowered 1Life Healthcare from a “buy” rating to a “neutral” rating and lifted their price target for the company from $14.00 to $18.00 in a research note on Friday, July 22nd.
Hedge Funds Weigh In On 1Life Healthcare
Several hedge funds and other institutional investors have recently modified their holdings of ONEM. Aaron Wealth Advisors LLC acquired a new stake in 1Life Healthcare in the 1st quarter valued at about $212,000. Sandy Spring Bank lifted its position in 1Life Healthcare by 125.4% during the first quarter. Sandy Spring Bank now owns 3,500 shares of the company’s stock worth $39,000 after buying an additional 1,947 shares in the last quarter. CWM LLC boosted its stake in 1Life Healthcare by 102.7% during the second quarter. CWM LLC now owns 3,572 shares of the company’s stock worth $28,000 after buying an additional 1,810 shares during the last quarter. Eaton Vance Management grew its holdings in 1Life Healthcare by 300.0% in the 4th quarter. Eaton Vance Management now owns 3,856 shares of the company’s stock valued at $68,000 after buying an additional 2,892 shares in the last quarter. Finally, US Bancorp DE increased its stake in shares of 1Life Healthcare by 88.8% in the 1st quarter. US Bancorp DE now owns 4,492 shares of the company’s stock worth $50,000 after acquiring an additional 2,113 shares during the last quarter. 79.58% of the stock is owned by hedge funds and other institutional investors.
1Life Healthcare Price Performance
Shares of NASDAQ:ONEM opened at $17.15 on Friday. 1Life Healthcare has a twelve month low of $5.94 and a twelve month high of $24.59. The company has a current ratio of 2.59, a quick ratio of 2.56 and a debt-to-equity ratio of 0.19. The company has a market cap of $3.35 billion, a PE ratio of -8.75 and a beta of 2.47. The company’s 50 day moving average is $17.13 and its 200 day moving average is $12.01.
1Life Healthcare (NASDAQ:ONEM – Get Rating) last released its quarterly earnings data on Wednesday, August 3rd. The company reported ($0.48) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.48). 1Life Healthcare had a negative net margin of 40.24% and a negative return on equity of 21.05%. The firm had revenue of $255.84 million for the quarter, compared to analyst estimates of $263.99 million. On average, sell-side analysts forecast that 1Life Healthcare will post -1.91 EPS for the current year.
About 1Life Healthcare
1Life Healthcare, Inc operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider 1Life Healthcare, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and 1Life Healthcare wasn’t on the list.
While 1Life Healthcare currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
Source: marketbeat.com
